Selected research
Industry Research
ELISA Service Industry Research Report 2026
Market perspective
The global ELISA Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the ELISA Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the ELISA Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the ELISA Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of ELISA Service include Virology Research Services Ltd, ACROBiosystems, Boster Bio, RayBiotech, Inc, Precision Medicine Group, LLC, Bio-Techne, Cellular Technology Limited（immunospot）, Sino Biological, Inc and R&D Systems, Inc, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global ELISA Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to ELISA Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
ELISA Service Market by Company
Virology Research Services Ltd
ACROBiosystems
Boster Bio
RayBiotech, Inc
Precision Medicine Group, LLC
Bio-Techne
Cellular Technology Limited（immunospot）
Sino Biological, Inc
R&D Systems, Inc
ProteoGenix
Eve Technologies
NorthEast BioAnalytical Laboratories LLC
mabtech
Pestka Biomedical Laboratories, Inc
Thermo Fisher Scientific
Antibodies Incorporated
Kaneka Eurogentec S.A
ELISA Service Segment by Type
Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA
ELISA Service Segment by Application
Disease Diagnosis
Vaccine Effectiveness Evaluation
Drug Development
Allergen Testing
Others
ELISA Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ELISA Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of ELISA Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ELISA Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of ELISA Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Direct ELISA
- Indirect ELISA
- Sandwich ELISA
- Competitive ELISA
Applications
- Disease Diagnosis
- Vaccine Effectiveness Evaluation
- Drug Development
- Allergen Testing
- Others
Companies covered
- Virology Research Services Ltd
- ACROBiosystems
- Boster Bio
- RayBiotech, Inc
- Precision Medicine Group, LLC
- Bio-Techne
- Cellular Technology Limited（immunospot）
- Sino Biological, Inc
- R&D Systems, Inc
- ProteoGenix
- Eve Technologies
- NorthEast BioAnalytical Laboratories LLC
- mabtech
- Pestka Biomedical Laboratories, Inc
- Thermo Fisher Scientific
- Antibodies Incorporated
- Kaneka Eurogentec S.A
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 ELISA Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Direct ELISA
- 2.2.3 Indirect ELISA
- 2.2.4 Sandwich ELISA
- 2.2.5 Competitive ELISA
- 2.3 ELISA Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Disease Diagnosis
- 2.3.3 Vaccine Effectiveness Evaluation
- 2.3.4 Drug Development
- 2.3.5 Allergen Testing
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 ELISA Service Breakdown Data by Type
- 3.1 Global ELISA Service Historic Market Size by Type (2021-2026)
- 3.2 Global ELISA Service Forecasted Market Size by Type (2027-2032)
4 ELISA Service Breakdown Data by Application
- 4.1 Global ELISA Service Historic Market Size by Application (2021-2026)
- 4.2 Global ELISA Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global ELISA Service Market Perspective (2021-2032)
- 5.2 Global ELISA Service Growth Trends by Region
- 5.2.1 Global ELISA Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 ELISA Service Historic Market Size by Region (2021-2026)
- 5.2.3 ELISA Service Forecasted Market Size by Region (2027-2032)
- 5.3 ELISA Service Market Dynamics
- 5.3.1 ELISA Service Industry Trends
- 5.3.2 ELISA Service Market Drivers
- 5.3.3 ELISA Service Market Challenges
- 5.3.4 ELISA Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top ELISA Service Players by Revenue
- 6.1.1 Global Top ELISA Service Players by Revenue (2021-2026)
- 6.1.2 Global ELISA Service Revenue Market Share by Players (2021-2026)
- 6.2 Global ELISA Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of ELISA Service Head Office and Area Served
- 6.4 Global ELISA Service Players, Product Type & Application
- 6.5 Global ELISA Service Manufacturers Established Date
- 6.6 Global ELISA Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America ELISA Service Market Size (2021-2032)
- 7.2 North America ELISA Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America ELISA Service Market Size by Country (2021-2026)
- 7.4 North America ELISA Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe ELISA Service Market Size (2021-2032)
- 8.2 Europe ELISA Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe ELISA Service Market Size by Country (2021-2026)
- 8.4 Europe ELISA Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific ELISA Service Market Size (2021-2032)
- 9.2 Asia-Pacific ELISA Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific ELISA Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific ELISA Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America ELISA Service Market Size (2021-2032)
- 10.2 South America ELISA Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America ELISA Service Market Size by Country (2021-2026)
- 10.4 South America ELISA Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa ELISA Service Market Size (2021-2032)
- 11.2 Middle East & Africa ELISA Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa ELISA Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa ELISA Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Virology Research Services Ltd
- 12.1.1 Virology Research Services Ltd Company Information
- 12.1.2 Virology Research Services Ltd Business Overview
- 12.1.3 Virology Research Services Ltd Revenue in ELISA Service Business (2021-2026)
- 12.1.4 Virology Research Services Ltd ELISA Service Product Portfolio
- 12.1.5 Virology Research Services Ltd Recent Developments
- 12.2 ACROBiosystems
- 12.2.1 ACROBiosystems Company Information
- 12.2.2 ACROBiosystems Business Overview
- 12.2.3 ACROBiosystems Revenue in ELISA Service Business (2021-2026)
- 12.2.4 ACROBiosystems ELISA Service Product Portfolio
- 12.2.5 ACROBiosystems Recent Developments
- 12.3 Boster Bio
- 12.3.1 Boster Bio Company Information
- 12.3.2 Boster Bio Business Overview
- 12.3.3 Boster Bio Revenue in ELISA Service Business (2021-2026)
- 12.3.4 Boster Bio ELISA Service Product Portfolio
- 12.3.5 Boster Bio Recent Developments
- 12.4 RayBiotech, Inc
- 12.4.1 RayBiotech, Inc Company Information
- 12.4.2 RayBiotech, Inc Business Overview
- 12.4.3 RayBiotech, Inc Revenue in ELISA Service Business (2021-2026)
- 12.4.4 RayBiotech, Inc ELISA Service Product Portfolio
- 12.4.5 RayBiotech, Inc Recent Developments
- 12.5 Precision Medicine Group, LLC
- 12.5.1 Precision Medicine Group, LLC Company Information
- 12.5.2 Precision Medicine Group, LLC Business Overview
- 12.5.3 Precision Medicine Group, LLC Revenue in ELISA Service Business (2021-2026)
- 12.5.4 Precision Medicine Group, LLC ELISA Service Product Portfolio
- 12.5.5 Precision Medicine Group, LLC Recent Developments
- 12.6 Bio-Techne
- 12.6.1 Bio-Techne Company Information
- 12.6.2 Bio-Techne Business Overview
- 12.6.3 Bio-Techne Revenue in ELISA Service Business (2021-2026)
- 12.6.4 Bio-Techne ELISA Service Product Portfolio
- 12.6.5 Bio-Techne Recent Developments
- 12.7 Cellular Technology Limited（immunospot）
- 12.7.1 Cellular Technology Limited（immunospot） Company Information
- 12.7.2 Cellular Technology Limited（immunospot） Business Overview
- 12.7.3 Cellular Technology Limited（immunospot） Revenue in ELISA Service Business (2021-2026)
- 12.7.4 Cellular Technology Limited（immunospot） ELISA Service Product Portfolio
- 12.7.5 Cellular Technology Limited（immunospot） Recent Developments
- 12.8 Sino Biological, Inc
- 12.8.1 Sino Biological, Inc Company Information
- 12.8.2 Sino Biological, Inc Business Overview
- 12.8.3 Sino Biological, Inc Revenue in ELISA Service Business (2021-2026)
- 12.8.4 Sino Biological, Inc ELISA Service Product Portfolio
- 12.8.5 Sino Biological, Inc Recent Developments
- 12.9 R&D Systems, Inc
- 12.9.1 R&D Systems, Inc Company Information
- 12.9.2 R&D Systems, Inc Business Overview
- 12.9.3 R&D Systems, Inc Revenue in ELISA Service Business (2021-2026)
- 12.9.4 R&D Systems, Inc ELISA Service Product Portfolio
- 12.9.5 R&D Systems, Inc Recent Developments
- 12.10 ProteoGenix
- 12.10.1 ProteoGenix Company Information
- 12.10.2 ProteoGenix Business Overview
- 12.10.3 ProteoGenix Revenue in ELISA Service Business (2021-2026)
- 12.10.4 ProteoGenix ELISA Service Product Portfolio
- 12.10.5 ProteoGenix Recent Developments
- 12.11 Eve Technologies
- 12.11.1 Eve Technologies Company Information
- 12.11.2 Eve Technologies Business Overview
- 12.11.3 Eve Technologies Revenue in ELISA Service Business (2021-2026)
- 12.11.4 Eve Technologies ELISA Service Product Portfolio
- 12.11.5 Eve Technologies Recent Developments
- 12.12 NorthEast BioAnalytical Laboratories LLC
- 12.12.1 NorthEast BioAnalytical Laboratories LLC Company Information
- 12.12.2 NorthEast BioAnalytical Laboratories LLC Business Overview
- 12.12.3 NorthEast BioAnalytical Laboratories LLC Revenue in ELISA Service Business (2021-2026)
- 12.12.4 NorthEast BioAnalytical Laboratories LLC ELISA Service Product Portfolio
- 12.12.5 NorthEast BioAnalytical Laboratories LLC Recent Developments
- 12.13 mabtech
- 12.13.1 mabtech Company Information
- 12.13.2 mabtech Business Overview
- 12.13.3 mabtech Revenue in ELISA Service Business (2021-2026)
- 12.13.4 mabtech ELISA Service Product Portfolio
- 12.13.5 mabtech Recent Developments
- 12.14 Pestka Biomedical Laboratories, Inc
- 12.14.1 Pestka Biomedical Laboratories, Inc Company Information
- 12.14.2 Pestka Biomedical Laboratories, Inc Business Overview
- 12.14.3 Pestka Biomedical Laboratories, Inc Revenue in ELISA Service Business (2021-2026)
- 12.14.4 Pestka Biomedical Laboratories, Inc ELISA Service Product Portfolio
- 12.14.5 Pestka Biomedical Laboratories, Inc Recent Developments
- 12.15 Thermo Fisher Scientific
- 12.15.1 Thermo Fisher Scientific Company Information
- 12.15.2 Thermo Fisher Scientific Business Overview
- 12.15.3 Thermo Fisher Scientific Revenue in ELISA Service Business (2021-2026)
- 12.15.4 Thermo Fisher Scientific ELISA Service Product Portfolio
- 12.15.5 Thermo Fisher Scientific Recent Developments
- 12.16 Antibodies Incorporated
- 12.16.1 Antibodies Incorporated Company Information
- 12.16.2 Antibodies Incorporated Business Overview
- 12.16.3 Antibodies Incorporated Revenue in ELISA Service Business (2021-2026)
- 12.16.4 Antibodies Incorporated ELISA Service Product Portfolio
- 12.16.5 Antibodies Incorporated Recent Developments
- 12.17 Kaneka Eurogentec S.A
- 12.17.1 Kaneka Eurogentec S.A Company Information
- 12.17.2 Kaneka Eurogentec S.A Business Overview
- 12.17.3 Kaneka Eurogentec S.A Revenue in ELISA Service Business (2021-2026)
- 12.17.4 Kaneka Eurogentec S.A ELISA Service Product Portfolio
- 12.17.5 Kaneka Eurogentec S.A Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst